Interview with Nihal Aygun, CEO, Corena Turkey
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
Address: 2545. Sokak Toyko Villalari No:14 Umitkoy / Yenimahalle / Ankara / TURKEY
2545. Sokak Toyko Villalari No:14 Umitkoy / Yenimahalle / Ankara / Turkey
Tel: +90 312 236 43 34
Web: http://www.corena.com.tr/
CORENA has been successfully serving to its clients worldwide since 1998 with an overall focus to help clients locate new areas of expansion within the marketplace, to implement best practices for achieving success and to achieve high growth levels in these areas of opportunity. With our extensive geographic coverage we are committed to consistently striving to deliver relevant tailored solutions,
Authenticity, happiness, passion, commitment and responsibility are the key words in the daily life of our company…
FIELD OF ACTIVITIES
INTERNATIONAL SALES
CLINICAL TRIALS
Weprovide governments, multilateral and procurement agencies, non-governmental organisations, charities, missionary groups, pharmaceutical wholesalers, hospitals and retail chemistsin 53 differentcountrieswithwiderangeof productssuch as:
PHARMACEUTICALS
OTC PRODUCTS
VACCINES
MEDICAL DEVICES
COSMETICS
DIET PRODUCTS
VETERINARIAN PRODUCTS
DIAGNOSTICS
CLINICAL TRIALS
CORENA dispatchesproductstoclinicaltrial centres across the worldwiththebestdeliveryconditonssuch as:
Cold chain and ambient supply chain
Fully tracked deliveries including temperature control
Specialized andExperienced Team
CORENA’S DIFFERENCE
With 15 yearsexperiece of sourcingquality- assuredandreliableproducts, wehavebeenabletobuildupstrong global supplierrelationship,andyou can alwaysdepend on thequality of CORENA’sproducts, BECAUSE WE DIFFER FROM THE OTHERS IN MANY ASPECTS SUCH AS:
OFFERINGS
LOGISTICS
SECURITY
LICENCES
CONFIDENTIALTY
EXPERIENCED AND SPECIALIZED TEAM
OUR OFFERINGS
Whereveryouare,operateorwork, our experienced multi-lingual team are able to source pharmaceuticals and other medical products for you in any quantity at any time and at any competitive price.
Weoffer awiderange of packagingoptionsincludingvalidatedboxesandmaterialsforcoldchainandhazardousitems.
Wearealsoquiteeffectivewiththeshipment of theorders. 90 % of yourproductsaredispatchedwithin 3-4 daysdays. As forthe life-savingmedicineswe do ourbesttosendthem on thesameday.
STORAGE
Temperature of theproducts is monitored and recorded periodically. The records of temperature are reviewed regularly.
Storage facilities arealwaysclean and free from litter, dust and pests.
Adequate precautions aretaken against spillage or breakage, attack by micro-organisms and cross contamination.
There is a system to ensure stock rotation (‘first in first out’) with regular and frequent checks that the system is operating correctly.
Products beyond their expiry date or shelf life are separated from usable stock and neither sold nor supplied.
Medicinal products with broken seals, damaged packaging, or suspected of possible contamination arewithdrawn from saleable stock, and if not immediately destroyed, they arekept in a clearly separated area in order not to be soldbe sold mistakenly, ortoavoidthecontamination o otherproducts.
LOGISTICS
CORENA will manage your shipment and ensure that your goods arrive in the best conditions at the right time and place, and with all correct documentation.
We offer:
• Delivery within 3-4 daysfor most products depending on destination
• Specialist packaging to ensure perfect condition on arrival including temperature sensitive, dangerous/hazardous and fragile
• Competitive freight alternatives around the world
COLD CHAIN
We frequently ship to over 53 countries and our specialist logistics team ensures deliveries go out on time from our fully licensed warehouse.
Cold chain deliveries:
CORENA has extensive experience in shipping temperature-sensitive goods across the globe using either refrigerated transport or insulated packaging.
We have full SOPs to cover all elements of temperature-sensitive transport and these are available for inspection by our clients. CORENA uses temperature boxes and tracks all shipments using temperature loggers. We are, of course, willing to abide by any trial protocols and use differing technologies if necessary.
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
Murat Barlas, the longest serving board member for the Turkish Pharmaceutical Manufacturers Association, discusses the need for a new perspective in government-industry relations in the Turkish pharmaceutical industry, and the…
The Turkish minister of labour and social security comments on the country’s deep commitment to providing for the health of citizens while maintaining sustainability and continuous improvement of services. How…
Novo Nordisk Turkey has taken a degree of leadership by working to facilitate and encourage cooperation and collaboration between different stakeholders in the diabetes management ecosystem. For general manager Şebnem…
Turkey is a key market in the region for Servier, says general manager Philippe Méa, largely due to the country’s relatively strong and stable vision for the healthcare industry. The…
Turkey has been a high priority market for Actelion since the company’s relatively recent beginnings, and the general manager of the local affiliate discusses his affiliate efforts to improve awareness…
Bayer Turkey’s healthcare division head discusses how the company adapted to the post 2009 pharmaceutical pricing environment by shrinking their portfolio and focusing strongly on key growth products, launched recently…
Medipol hospital’s medical director discusses the private institution’s current role in the Turkish healthcare system, and their plans for expansion in the coming years. How did Medipol come into existence,…
Professor Burak Erman, the leader of the Drug Research Center at Koç University, and his colleague Hakan Orer, discuss the early activities of the center as a catalyst for collaboration…
Janssen’s MD in Turkey discusses how true innovation is still recognized in Turkey, and how products that meet unmet medical needs are given early access to the country and reimbursement.…
IMS’s top consultant in Turkey discusses the common pattern that companies in Turkey have and must follow to adapt to today’s market, and the importance of heeding market signals, such…
The managing director of Otsuka’s 50-50 joint venture with Turkish giant Abdi Ibrahim, Abdi Ibrahim Otsuka, discusses the mutual advantage the companies can offer each other, and branding Abdi Ibrahim…
Turkey’s Minister of Health discusses the major achievements of his party in the area of healthcare since 2003, and the key priorities for the country’s healthcare system moving forward. During…
See our Cookie Privacy Policy Here